Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: J Adv Nurs. 2010 Aug 16;66(11):2560–2572. doi: 10.1111/j.1365-2648.2010.05400.x

Table 3.

The Criterion validity of the HIV Meditation Taking Self-Efficacy Scale (HIV MT SES)

HIV medication-taking self-efficacy (0 week)
Overall scale Self-efficacy
beliefs: SEB
Outcome
expectancy: OE
SEB at baseline .91*** - -
OE at baseline .68*** .37*** -

Overall scale (12wk) .66*** .52*** .52***
SEB at 12wk .58*** .55*** .32**
OE at 12wk .54*** .30** .66***

Energy/fatigue .38*** .28*** .37***
Mental Health .38*** .29*** .37***
Complexity of medication regimen −.20** −.18** −.16**
Impact of side effects −.29*** −.24*** −.40***
Social Support .35*** .27*** .37***
Self-report medication-taking (baseline) .58*** .61*** .24***
Self-report medication-taking (12wk) .41*** .43*** .14*
*

p <.05

**

p<.01

***

p<.001

indicates discriminate validity of HIV MT SES

indicates predictive validity of the HIV MT SES